Korean drugmakers seeking to develop time release technology of combination drugs

Published: 2010-08-30 06:59:00

Updated: 2010-08-30 06:59:00

More and more pharmaceutical companies in Korea are focusing on the development of time release technology, such as also known as sustained-release (SR), sustained-action (SA), extended-release (ER, XR, or XL), time-release or timed-release, controlled-release (CR), modified release (MR), or continuous-release (CR or Contin), based on their platform formulation method to boost their sales.

T...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.